Scott D. Olsonمشاهده پروفایل
دانشیار
Dr. Scott D. Olson is an Associate Professor at the University of Texas Health Science Center in the Department of Pediatric Surgery, where he has been conducting research since September 2011. His academic journey includes a BS in Biochemistry from Texas Christian University, a PhD in Molecular and Cellular Biology from Tulane University, and postdoctoral training in the Stem Cell Program at University of California at Davis Health System. Dr. Olson's research centers on mesenchymal stem cells (MSCs) and their therapeutic applications, particularly for Traumatic Brain Injury (TBI). His work explores how MSCs can immunomodulate and restore homeostasis, with a focus on their impressive ability to control immune system activation in inflammatory conditions. His laboratory conducts comparative studies of different MSC preparations to identify optimal therapeutic candidates and investigates MSC interactions with immune cells, particularly monocytes and macrophages. Dr. Olson's research program has evolved from studying MSC applications for Huntington's Disease at UC Davis to focusing on TBI treatment at UTHealth. His work demonstrates a consistent theme of leveraging MSCs' innate therapeutic abilities to develop improved cellular therapies. The research shows particular promise in conditions involving prolonged or exaggerated inflammation, where MSCs have demonstrated significant efficacy in clinical trials. His scientific contributions span multiple disciplines including regenerative medicine, neurology, immunology, and trauma surgery. Dr. Olson has published extensively on MSC therapies, with recent work expanding into synthetic biology approaches and novel drug delivery systems. His collaborative research extends across multiple institutions and specialties, reflecting the interdisciplinary nature of modern regenerative medicine research. Dr. Olson's laboratory focuses on three primary research directions: Comparing different MSC and MSC-like cell preparations to identify optimal therapeutic candidates Studying MSC interactions with specific immune cell populations, particularly their influence on monocyte and macrophage phenotype Developing mixed cell preparations using selectively permeable scaffolds for implantable therapeutic constructs His work aims to translate basic MSC research into clinical applications, with a particular emphasis on improving treatments for Traumatic Brain Injury through better understanding of MSC mechanisms and therapeutic potential.

